Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology

2005 ◽  
Vol 96 (7) ◽  
pp. 1031-1035 ◽  
Author(s):  
Jay D. Raman ◽  
Casey K. Ng ◽  
Stephen A. Boorjian ◽  
E. Darracott Vaughan ◽  
R. Ernest Sosa ◽  
...  
Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. S142-S143
Author(s):  
A. Hidoussi ◽  
M. Jaidane ◽  
W. Hamida ◽  
Y. Kallel ◽  
A. Slama ◽  
...  

2011 ◽  
Vol 43 (3) ◽  
pp. 729-735 ◽  
Author(s):  
Bogomir Milojevic ◽  
Milan Djokic ◽  
Sandra Sipetic-Grujicic ◽  
Dragica Milenkovic-Petronic ◽  
Aleksandar Vuksanovic ◽  
...  

Urology ◽  
2005 ◽  
Vol 65 (2) ◽  
pp. 279-283 ◽  
Author(s):  
Yoshiyuki Matsui ◽  
Noriaki Utsunomiya ◽  
Kentaro Ichioka ◽  
Norihumi Ueda ◽  
Koji Yoshimura ◽  
...  

1996 ◽  
Vol 63 (1) ◽  
pp. 25-28
Author(s):  
S. Cosciani Cunico ◽  
E. Frego ◽  
M. Scanzi ◽  
T. Zanotelli ◽  
E. Panizza ◽  
...  

— The incidence of upper urinary tract transitional cell carcinoma (UTTCC) following a bladder cancer has been studied in 1731 urothelial tumours from 1984 to 1995. The UTTCC were 88: 59 primitive, 6 synchronous and 23 metachronous after a bladder cancer (1672). Of the 23 metachronous UTTCC, 17 followed TURBT (17/1310 = 1.3%): the latency period was very long (64.8 months); grading and staging were mostly similar to the foregoing bladder tumours. A vesicoureteral reflux raised the metachronous UTTCC rate to 17.6%. A neoplastic distal ureter was found during radical cystectomy in 2.24%. During the follow-up of 362 radical cystectomies 6 (1.65%) metachronous UTTCC were recorded. A metachronous UTTCC is always a poor prognostic sign. There are some controversies concerning this topic such as: the role of IVP and urine cytology in the follow-up of bladder cancer, the management of a vesicoureteral reflux in bladder cancer and the choice of a urinary diversion in the event of an upper urinary tract at high risk for UTTCC.


Sign in / Sign up

Export Citation Format

Share Document